PremiumThe FlyCardio Diagnostics announces 1-for-30 reverse stock split Cardio Diagnostics Unveils Strategic Vision for Future Growth Cardio Diagnostics files $50M mixed securities shelf PremiumThe FlyCardio Diagnostics achieves SOC 2 Type I compliance certification Cardio Diagnostics price target raised to $2 from $1.35 at Benchmark Cardio Diagnostics : PrecisionCHD test may save insurers $13M annually PremiumThe FlyCardio Diagnostics announces issuance of patent from USPTO Cardio Diagnostics teams with FMS to deploy tests to certain Walmart locations Cardio Diagnostics Raises $1M in Private Placement 
